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Symbiosis Receptor KinasePlant receptor-like kinases (RLKs) are distinguished by having a tyrosine in the ‘gatekeeper’
position. Previously we reported Symbiosis Receptor Kinase from Arachis hypogaea (AhSYMRK) to
autophosphorylate on the gatekeeper tyrosine (Y670), though this phosphorylation was not neces-
sary for the kinase activity. Here we report that recombinant catalytic domain of AhSYMRK with a
phosphomimic substitution in the gatekeeper position (Y670E) is catalytically almost inactive and
is conformationally quite distinct from the corresponding native enzyme. Additionally, we show
that gatekeeper-phosphorylated AhSYMRK polypeptides are inactive and depletion of this inactive
form leads to activation of intramolecular autophosphorylation of AhSYMRK. Together, our results
suggest gatekeeper tyrosine autophosphorylation to be autoinhibitory for AhSYMRK.
Structured summary of protein interactions:
AhSYMRK and AhSYMRK bind by molecular sieving (1, 2)
AhSYMRK and AhSYMRK phosphorylate by protein kinase assay (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction causes inactivation [6]. Structural analysis suggested that the bulk-Gatekeeper position in protein kinases is located on a conserved
b5 strand, distal to the active site and is adjacent to an intrinsically
ﬂexible hinge region that connects the N- and C-terminal lobes of
the enzyme [1–3]. The position is referred to as a gatekeeper
because it ﬂanks a hydrophobic pocket at the rear of the catalytic
cleft and confers selectivity for binding nucleotides and small-mol-
ecule inhibitors in the pocket [4,5]. Apart from being the architect
of this deep cleft, gatekeeper position has gained more importance
because several evidences indicate that protein kinases have
adopted different mechanisms of regulation mediated by their
respective gatekeeper residue and/or the hinge region [4,6]. Bulkier
hydrophobic residue at gatekeeper position has been shown to
activate tyrosine kinases whereas smaller residue, like glycine,ier residue stabilises the active conformation by strengthening a
‘hydrophobic spine’, whereas the smaller residue inactivates the
kinase by disruption of the same hydrophobic connectivity [4].
Emrick et al. had demonstrated the role of the gatekeeper residue
in restraining auto-activation of ERK2 in the absence of upstream
signalling [7]. Recent evidences have directly demonstrated that
backbone ﬂexibility within the hinge region adjacent to gatekeeper
residue is an important determinant of ERK2 activation [8].
Plant receptor-like kinases (RLKs) and receptor-like cytoplasmic
kinases (RLCKs) share a common feature with the animal interleu-
kin-1 receptor-associated kinase (IRAK)/Pelle family of soluble
kinases that distinguishes them from all other kinases: the
presence of a Tyr residue in their gatekeeper position [9]. Several
evidences have indicated the importance of gatekeeper tyrosine
in determining the active conformation of these receptor or non-
receptor kinases. In IRAK4, the invariant glutamate from a-helix
C forms hydrogen bonds with gatekeeper Tyr as well as the Phe
residue in the DFG motif, suggesting the importance of gatekeeper
Tyr in regulation of this kinase [10,11]. Structural analysis of gate-
keeper residue arrangement in BRASSINOSTEROID-INSENSITIVE 1
(BRI1) and BRI1-associated kinase 1 (BAK1) of Arabidopsis thaliana
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the invariant gatekeeper tyrosine with the conserved Lys/Glu salt-
bridge (residue 911/927 and 317/334 in BRI1 and BAK1, respec-
tively) are hall-marks of activated plant receptor-like kinases
[12,13]. The importance of gatekeeper tyrosine in the functional
outputs of RLKs/RLCKs is also evidenced. For example, structure–
mimic substitutions of gatekeeper Tyr–Phe in BRI1 (Y956F) [14],
or in an RLCK like Botrytis-induced kinase 1 (BIK1, Y150F) [15],
blocks their in vitro kinase activity as well as biological function.
In lysin motif domain-containing receptor like kinase-3 (LYK3), a
gatekeeper mutant (Y390F) retained partial kinase activity, but
mutant LYK3 was biologically active [9]. In contrast, in gatekeeper
mutants Y363F of BAK1 [16] or Y670F of Symbiosis Receptor
Kinase of Arachis hypogaea [17], the catalytic potential of the RLKs
remain unaffected. This indicates that unlike BRI1 or BIK1, for RLKs
like SYMRK or BAK1, the H-bonding network involving the free
hydroxyl group of gatekeeper tyrosine was not essential for their
in vitro catalytic activity. Considering the contrasting effects of
gatekeeper substitution in RLKs, the involvement of free hydroxyl
group of gatekeeper tyrosine in an H-bonding network cannot be
considered as a quintessential signature of the activated state for
all RLKs.
Symbiosis Receptor Kinase (SYMRK) is an orphan RLK involved
in root nodule symbiosis [18,19]. Earlier, we have demonstrated
that gatekeeper Tyr (Y670) is the predominant site of tyrosine
autophosphorylation in A. hypogaea SYMRK (AhSYMRK) both
in vitro and in planta [17]. Catalytic activity of Y670F mutant of
AhSYMRK, indicated that autophosphorylation on gatekeeper Tyr
was not a prerequisite for AhSYMRK to be an active kinase [17].
Here we report that recombinant catalytic domain of AhSYMRK
with a phosphomimic substitution in the gatekeeper position
(Y670E) is conformationally distinct with an almost loss of cata-
lytic activity. We also show that the gatekeeper-phosphorylated
AhSYMRK polypeptides were almost inactive indicating that the
negative charge of the phosphate group negatively affects the cat-
alytic activity of AhSYMRK. Depletion of this inactive form acti-
vated intramolecular autophosphorylation of AhSYMRK,
suggesting gatekeeper tyrosine autophosphorylation to be autoin-
hibitory for this RLK.2. Experimental procedures
2.1. Cloning, mutagenesis, expression and puriﬁcation of recombinant
AhSYMRK
Ampliﬁcation, sub-cloning, mutagenesis, expression and puriﬁ-
cation of recombinant AhSYMRK kinase domain polypeptides were
performed as described previously [17]. The primers used for
developing Y670E mutant were F-50GATTCTCGTGGAGCCTTTTAT
GTC30 and B-50GACATAAAAGGCTCCACGAGAATC30. Puriﬁcation of
AhSYMRK and its mutant polypeptides through FPLC was per-
formed on Superose 6 10/300 GL column (GE Healthcare) at a ﬂow
rate of 0.5 ml/min using a buffer containing 25 mM Tris–HCl at pH
8.0, 150 mM NaCl and 2.5 mM EDTA and 250 ll fractions were col-
lected. Standards for the gel-ﬁltration column (Gel Filtration Cali-
bration Kit, GE Healthcare) were Ferritin (440 kDa), Aldolase
(158 kDa), Ovalbumin (44 kDa), and Carbonic Anhydrase
(29 kDa). Eluted fractions corresponding to each peak were col-
lected and distributed into 25 ll aliquots, quickly frozen in dry
ice and stored at 80 C for further analysis.
2.2. Kinase assay and phosphoamino acid analysis
Kinase autophosphorylation assays were carried out as
described earlier [17,20,21]. Immunoblotting was conducted asper manufacturer’s instructions with monoclonal a-pY (1:3000)
and polyclonal a-pT (1:3000) from Cell Signaling Technology,
polyclonal a-His6 (1:2000) and monoclonal a-pS Q5 (1:100) from
Qiagen, polyclonal a-SYMRK (raised in rabbit against the cytosolic
domain of AhSYMRK as described earlier [22]) and custom-made
antibody against the synthetic peptide (665-QQILVpYPFMS-674)
(Imgenex India) [17]. To monitor the phosphorylation status, Pro-
Q Diamond Phosphoprotein Stain (Invitrogen) was used according
to manufacturer’s protocol and data were obtained using Typhoon
Trio+ Scanner (GE Heathcare).
2.3. Circular dichroism (CD)
His6-AhSYMRK (wild-type (WT)) and its mutants (Y670F, Y670E
and K625E) were dialyzed overnight against 5 mM Tris–HCl (pH
8.0) and 25 mM NaCl at 4 C. Far-UV spectra with excitation
wavelengths ranging from 200 to 260 nm were recorded for each
protein (ﬁnal concentration 0.1 mg/ml) in Jasco J-815 CD Spec-
trometer, in a 0.1 cm path length cuvette. The results were
expressed in Molar Ellipticity [23].
2.4. Fluorescence measurements
AhSYMRK and its mutants were dialyzed overnight against
5 mM Tris–HCl (pH 8.0) and 25 mM NaCl and were brought to
A280 of 0.1 O.D. Measurements were conducted in a 1 cm cuvette
at room temperature in a Cary Eclipse Fluorescence Spectropho-
tometer (Varian). Scans were performed at an excitation wave-
length of 280 nm, a bandwidth of 5 nm with a scan speed of
240 nm/min [24].
2.5. Limited proteolysis
For limited proteolysis with trypsin, 40 lg of puriﬁed protein
was diluted to 250 ll reaction volume containing 50 mM NH4-
HCO3, pH 7.8 and incubated at 37 C with Trypsin (Promega) at a
1:1000 (w/w) enzyme: substrate ratio [24]. 25 ll aliquots were
removed at ﬁxed time points, and the reaction was stopped by
the addition of 2X Laemmli buffer and boiling for 5 min. Digested
protein samples (4 lg/lane) were separated in a 7.5% SDS–PAGE
and gels were stained with Commassie Brilliant blue R250.
2.6. Immunoprecipitation
AhSYMRK expressed in Escherichia coliwas immunoprecipitated
with monoclonal a-pY antibody (Cell Signaling Technology) under
binding conditions described previously with modiﬁcations [21]. In
brief, 400 lg of protein was incubated in a total reaction volume of
300 ll in the presence of 20 mM HEPES pH 7.4, 150 mM NaCl and
1 lg of the corresponding antibody. Incubation was performed for
4 h at 4 C. Protein A Sepharose Fast Flow beads (GE Healthcare)
were added, gently mixed for 1 h and washed ﬁve times with
20 mM HEPES pH 7.4 and 150 mMNaCl. The bound AhSYMRK from
the immunoprecipitate was eluted with 2 M NaCl and immediately
desalted. 0.2–0.5 lg of the bound and unbound fractions were used
for immunoblotting and kinase activity assay.
2.7. Homology modeling analysis
AhSYMRK kinase domain sequence (Uniprot ID: E6YC17) was
subjected to HHPRED [25] server for the prediction of secondary
and tertiary structure. Fold prediction results suggest strong struc-
tural similarity between AhSYMRK kinase domain and human
IRAK4 kinase domain complexed with AMPPNP (PDB ID: 2OID;
chain B) [11]. Three-dimensional (3D) coordinates of AhSYMRK
was generated by MODELLER 9.8 [26] package using chain B of
A. Paul et al. / FEBS Letters 588 (2014) 2881–2889 28832OID as ligand bound (‘active’) reference structure. 3D models
were ﬁltered based on the best energy parameters (MOLPDF and
DOPE scores) and were further validated using PROCHECK [27]
and Verify 3D [28] structure validation tools. Phospho-transfer
was performed using the CHIMERA software [29].
3. Results and discussion
3.1. Phosphomimic substitution in gatekeeper position (Y670E)
strongly reduces AhSYMRK activity
To clarify the consequence of gatekeeper Tyr phosphorylation
on AhSYMRK activity we initiated our investigation by making a
phosphomimic substitution of gatekeeper Tyr with Glu (Y670E)
in the His6-tagged core kinase domain (573–883 [17]) of AhSYMRK.
The idea was to check the effect of having negative charges in the
gatekeeper position buried in the hydrophobic pocket of the cata-
lytic cleft. The mutant polypeptide was expressed and subjected to
kinase reaction in vitro in presence of [c-32P]-ATP. The gatekeeper
substituted Y670F mutant was used as a control as there is no loss
of activity in Y670F AhSYMRK [17]. As indicated in Fig. 1A, the
wild-type AhSYMRK and the Y670F mutant actively autophosphor-
ylated but the activity of Y670E kinase was severely affected. Thus
a phosphomimic (Y670E) but not a structure-mimic (Y670F) sub-
stitution in the gatekeeper position has adverse effect on the cata-
lytic activity of AhSYMRK. In our previous report, we have shown
that AhSYMRK autophosphorylated in E. coli before extraction
[17] and to check the same in Y670E AhSYMRK, we harvested
E. coli cells overexpressing the polypeptide under denaturing con-
ditions in presence of 8 M urea before puriﬁcation. As indicated in
Fig. 1B, pTyr was undetectable in both the gatekeeper mutants
Y670E and Y670F indicating that these mutants were unable to
autophosphorylate on tyrosine residues. This observation is also
in consistence with gatekeeper Y670 being the primary site of tyro-
sine phosphorylation in AhSYMRK [17]. pThr and pSer was detect-
able in both the gatekeeper mutants though the level of
autophosphorylation was much lower in Y670E mutant kinase.
This indicates that Y670E can autophosphorylate on Ser/Thr but
its ability to phosphorylate on tyrosine residues is abolished.Fig. 1. Phosphomimic substitution in gatekeeper position (Y670E) substantially
reduces AhSYMRK activity. (A) Post puriﬁcation catalytic activity of recombinant
AhSYMRK and its gatekeeper mutants Y670F and Y670E: autoradiographs for
autophoshorylation. (B) Pre puriﬁcation phosphorylation status of AhSYMRK and its
gatekeeper mutants in E. coli: immunoblot analysis using a-pY, a-pT and a-pS
antibodies and staining using Pro-Q diamond phosphoprotein stain. (Autorad,
autoradiograph; CBB, coomassie brilliant blue; a-pS, anti-phosphoserine; a-pT,
anti-phosphothreonine; a-pY, anti-phosphotyrosine.)Finally, in accordance with Y670E having reduced catalytic activity,
phosphoprotein stain indicated the phosphorylation level in Y670E
to be very low as compared to WT SYMRK as well as the Y670F
mutant. These data indicated that negative charge in the gate-
keeper position adjacent to the hinge region of AhSYMRK adversely
affects its catalytic activity. This could either be because the nega-
tive charge has a destabilizing effect on the ATP-binding cleft of the
catalytic groove or the charged residue in the gatekeeper position
could also interfere with the hinge-bending motions of the two
lobes that are needed for adopting the catalytically competent
conformation of protein kinases [30]. Whatever be the case, the
gatekeeper residue does not appear to be directly involved in the
catalytic phosphotransfer by AhSYMRK since catalytic activity in
Y670E was not abolished like the K625E mutant, where the ATP-
binding invariant lysine was substituted with Glu [17]. Also, the
activity of Y670F mutant clearly showed that neither autophos-
phorylation on gatekeeper tyrosine (Y670) nor availability of free
hydroxyl group of Y670 was necessary for AhSYMRK activity.3.2. AhSYMRK (Y670E) is conformationally distinct
The native as well as the Y670E kinase domains were analysed
using spectroscopy and limited proteolysis to test the effect of
phosphomimic substitution at gatekeeper position on the confor-
mation of AhSYMRK. The far-UV circular dichroism spectra of WT
AhSYMRK and the gatekeeper mutants, Y670F and Y670E, had neg-
ative bands at 208 and 222 nm (Fig. 2A) which is similar to the
spectra reported for other receptor tyrosine kinases and supports
the ordered helical structure present in the core kinase domain
of AhSYMRK [24,31,32]. The spectral overlap between the active
kinases (WT and Y670F) and the gatekeeper mutant with strongly
reduced activity (Y670E) indicated that there was no signiﬁcant
variation in the secondary structure of the kinase associated with
its level of activation. The catalytically dead K625E mutant of
AhSYMRK also showed an overlapping spectrum with very small
and subtle changes implying that activation of AhSYMRK polypep-
tide is not associated with any signiﬁcant change of its secondary
structure. As opposed to this, variation in intrinsic tryptophan ﬂuo-
rescence emission (Fig. 2B) was indicative of the conformational
variations of active and inactive AhSYMRK polypeptides. The ﬂuo-
rescence was enhanced and red shifted in Y670E (kmax = 347 nm),
Y670F (kmax = 348 nm), and WT (kmax = 347 nm) in comparison to
the catalytically dead unphosphorylated K625E (kmax = 344 nm).
As phosphorylation status is indicative of kinase activity, the rela-
tively less ﬂuorescence emission of Y670E as compared to WT or
Y670F is in consistence with its strongly reduced (but not abol-
ished) catalytic activity. The conformations of AhSYMRK polypep-
tides were further studied using limited proteolysis to probe into
the accessibility in protein structure [33]. As shown in Fig. 2C,
the trypsin digestion patterns of WT AhSYMRK revealed that the
45 kDa band remained almost undigested after 15 min. In contrast,
in the catalytically dead kinase (K625E) the 45 kDa band
completely disappeared within 15 min with the concomitant
appearance of two visible bands at 42 kDa and 38 kDa indicating
this polypeptide to be completely digested under identical condi-
tions. These observations suggest that the native AhSYMRK with
a phosphorylated backbone has a rigid structure that is inaccessi-
ble to proteases but the catalytically dead unphosphorylated
AhSYMRK (K625E) has enhanced backbone ﬂexibility that
increased its susceptibility to proteases. In contrast to these
extremes, in both the gatekeeper mutants (Y670F and Y670E) the
45 kDa was partially digested after 15 min giving rise to the
42 kDa and 38 kDa bands indicating that these mutants have
restricted accessibility to trypsin. Thus both the gatekeeper
mutants have more backbone ﬂexibility than the WT AhSYMRK
Fig. 2. Conformational analysis of AhSYMRK and its mutant polypeptides. (A) An
overlay of the far-UV CD spectra of AhSYMRK and its mutants (WT—, K625E–––,
Y670F–––, Y670E). (B) The intrinsic ﬂuorescence spectra of WT—, K625E–––,
Y670F––– and Y670E polypeptides were recorded from 300 to 500 nm with
an excitation wavelength at 280 nm. (C) Tryptic ﬁngerprinting (at 1:1000 (w/w)
enzyme to substrate ratio) of WT, Y670F, Y670E and K625E were done for indicated
time points, followed by analysis in a 7.5% SDS–PAGE. Appearance of 42 kDa and
38 kDa bands are indicated with white and black arrowheads, respectively.
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polypeptide. It is of note that the gatekeeper mutants Y670F and
Y670E have similar backbone ﬂexibility in spite of having contrast-
ing catalytic potential.
In summary, in consistence with reduced catalytic potential of
Y670E mutant of AhSYMRK, both intrinsic ﬂuorescence emission
properties and protease accessibility indicated this polypeptide
to be conformationally distinct from both the active WT AhSYMRK
as well as its catalytically dead (K625E) counterpart.3.3. The propensity to oligomerise/dimerise in native AhSYMRK
is severely affected in Y670E mutant
Earlier reports indicated that intracellular domains of RLKs
possess an intrinsic propensity to form dimers and higher-order
oligomers [12,24]. We intended to check whether the native
AhSYMRK kinase domain shared this property of dimerisation
and/or oligomerisation and if yes, whether Y670E with a distinct
conformation differed with respect to the propensity of oligomer-
isation. The Ni–NTA enriched AhSYMRK polypeptide was clariﬁed
through size exclusion chromatography in a Superose 6 column
(GE Healthcare). WT AhSYMRK eluted predominantly at around
76 kDa (peak at 16.5 ml) where the catalytically inactive K625E
AhSYMRK eluted at around 40 kDa (peak at 17.28 ml) (Fig. 3A
and Supplemental Fig. S1), suggesting the active WT polypeptide
to be stable in a dimeric form. The monomeric form of K625E poly-
peptide ruled out the possibility of any inﬂuence of the His6-tag on
the dimerisation of AhSYMRK kinase domain (Fig. 3A). We noticed
that with increasing concentrations around 75 lM, the WT poly-
peptide showed an increased tendency to oligomerise and form
aggregates that eluted within void volume. This indicated that
the WT AhSYMRK had a propensity to oligomerise and this propen-
sity was concentration-dependent. Western blot analysis by a-His6
as well as a-SYMRK conﬁrmed that the void volume fraction as
well as other fractions eluting at higher molecular weight, con-
sisted of aggregates of the WT AhSYMRK polypeptide (Fig. 3B).
The void fractions were pooled as Peak1 (P1) and the dimeric
fractions as Peak2 (P2) and both were subjected to in vitro auto-
phosphorylation assay. As indicated in Fig. 3C, no autophosphory-
lation was detected in the void fraction (P1) of AhSYMRK. We also
tested the fractions eluting in between P1 and P2 containing higher
order oligomeric fractions (data not shown), but autophosphoryla-
tion was only detectable in the dimeric fraction of AhSYMRK.
Immunoblot analysis of P1 and P2 using a-pY670 (665–674) and
a-pY indicated that both the oligomeric and dimeric fractions of
WT AhSYMRK were autophosphorylated on gatekeeper tyrosine.
This indicated that AhSYMRK could actively autophosphorylate
on gatekeeper tyrosine before oligomerising into inactive higher
order structures. Immunoblot analysis also indicated that all
higher order oligomeric structures of AhSYMRK eluting in between
P1 and P2 were phosphorylated on gatekeeper tyrosine (data not
shown). In summary, our experiments suggested that the catalytic
domain of native AhSYMRK existed as a dimer and possessed an
intrinsic propensity to form higher-order oligomers. Since we only
used the kinase domain for our experiments the observed forma-
tion of the dimer or the higher order structures were not contrib-
uted by the juxtamembrane region (JM) or the C-terminal (CT)
region. This ligand independent formation of dimers by intracellu-
lar domains of receptor kinases have been noted earlier; for exam-
ple, receptor tyrosine kinases (RTKs) such as NGFR, EGFR, and EpoR
can exist as preformed dimers even in the absence of ligand [34–
38]. Among RLKs, BRI1 [39–41] and the S-locus receptor kinase
[42] have been shown to exist as ligand-independent dimers, but
the precise mechanism of dimer/oligomer formation in plant RLKs
and their in vivo relevance remains to be understood.
Our next objective was to check the propensity of oligomeri-
sation in the gatekeeper-substituted Y670E and Y670F mutants
(Fig. 3A). For this, the Ni–NTA enriched mutant polypeptides at
75 lM concentration were clariﬁed through size exclusion chro-
matography in a Superose 6 column under identical conditions.
As opposed to the native enzyme that eluted in dimeric form, both
the gatekeeper mutants appeared to elute as monomers (Fig. 3A).
The Y670E mutant eluted at 17.23 ml along with the catalytically
inactive K625E polypeptide at around 40 kDa (Supplemental
Fig. 3. Size exclusion chromatography of AhSYMRK polypeptides. (A) The Superose-6 FPLC absorbance proﬁle at 280 nm for WT AhSYMRK at increasing concentrations:
8 lM   , 38 lM——— and 75 lM—. The absorbance proﬁles are also shown for AhSYMRK mutants: K625E–––, Y670F––– and Y670E. The elution behaviour and the
apparent molecular mass of marker proteins separated on this column are shown above. Apparent molecular weights of AhSYMRK polypeptides were estimated from the
calibration curve (Supplemental Fig. S1). (B) Immunoblot analysis of FPLC puriﬁed fractions (P1, intermediate and P2) with a-SYMRK and a-His6 antibodies. (C)
Autophosphorylation of FPLC puriﬁed peak 1 (P1) and peak 2 (P2) fractions containing AhSYMRK; from left to right, Autoradiograph of autophosphorylation, immunoblot
analysis with a-pY670 (665–674), a-pY, and a-His6.
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eluted at 16.86 ml with a slightly higher calculated molecular
weight of 44 kDa indicating a change in hydrodynamic properties
associated with the active state of this mutant as compared to
the inactive Y670E and the K625E mutants. We also noted that
the yield of aggregates in the void region was considerably low
in Y670E and Y670F as compared to their monomeric form indicat-
ing that the tendency to oligomerise was largely decreased in
gatekeeper mutated polypeptides.
In this section we demonstrated that native AhSYMRK exists as
active homodimers and possesses an intrinsic propensity to form
catalytically inactive higher-order oligomers. Unlike BRI1, where
deletion of either JM or CT segments abolished dimer formation
[12], AhSYMRK kinase domain without its JM and CT segments
was sufﬁcient to form stable dimers. However substitution of
gatekeeper tyrosine in Y670E and Y670F mutants of AhSYMRK ren-
dered the kinase monomeric with decreased or no propensity to
oligomerise. This clearly indicates that presence of tyrosine in
the gatekeeper position is important for dimerisation as well as
oligomerisation of AhSYMRK. The effect of gatekeeper tyrosine in
dimerisation/oligomerisation could be mediated through
conformations of the kinase resulting from its hydrogen-bondinteractions with the conserved Lys/Glu salt-bridge (K625/E641)
which would be destabilised in both the gatekeeper mutants
(Y670E and Y670F) as well as the K625E mutant rendering them
monomeric. Alternatively, since the catalytically dead K625E
mutant failed to dimerise, it is possible that an active kinase
autophosphorylated in key positions including the gatekeeper
tyrosine is necessary for dimerisation. Intriguingly, BRI1 kinase
without its JM domain not only fails to oligomerise but also fails
to autophosphorylate on Tyr [12,14], implying the importance of
Tyr phosphorylation in determining the oligomeric state of an
RLK. The exact structural features contributing to the dimerisation
process of AhSYMRK however remain to be ascertained in future
experiments.
3.4. AhSYMRK phosphorylated on gatekeeper tyrosine is inactive
Our next objective was to directly demonstrate the effect of
gatekeeper phosphorylation on the catalytic activity of AhSYMRK
in the native polypeptide. For this we enriched the pTyr-containing
AhSYMRK by immuno-fractionation using a-pTyr (Fig. 4). The
sequentially immunoprecipitated AhSYMRK (Bound1 and Bound2)
and the corresponding unbound fractions (Unbound1 and
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respectively. Only a small fraction (<10%) of AhSYMRK could be
immuno-precipitated with a-pTyr (Fig. 4A). The poor immuno-pre-
cipitation of the gatekeeper-phosphorylated AhSYMRK could be
due to the relative inaccessibility of pY670. Immunoblot analysis
using a-pY670 (665–674) indicated that there was three-fold
enrichment of pY670 in ‘Bound’ fraction (pY670-enriched) whereas
only a two-fold reduction in the ‘Unbound’ fraction (pY670-
depleted) when compared to native AhSYMRK (Fig. 4A). The
pY670-enriched and pY670-depleted His6-AhSYMRK fractions
were subjected to in vitro autophosphorylation in presence of
[c-32P]-ATP as described in experimental procedures. As indicated
in Fig. 4B, the pY670-enriched form was barely active compared to
the pY670-depleted form, indicating that the pY670-containing
AhSYMRK represents an inactive form of the kinase. This inactiva-
tion could be due to introduction of charge in the ATP-binding cleft
that has a destabilizing effect similar to Y670E mutant. Introducing
a positive charge in the same position by substituting the gate-
keeper threonine with lysine has been shown to inactivate SrcFig. 4. AhSYMRK phosphorylated on gatekeeper tyrosine is inactive and inhibitory. (A)
pY670-enriched (Bound1 and Bound2) and pY670-depleted (Unbound1 and Unbound 2)
panel) and subjected to normalized densitometry (lower panel). Data are presented as mea
AhSYMRK: representative autoradiographs of autophosphorylation by the indicated B
AhSYMRK (WT) and pY670-depleted AhSYMRK (Unbound): (C, upper panel) WT AhSYMRK
for indicated time points: representative autoradiograph indicating the progress of autop
as means ± SEM (n = 3 experiments). (D) Progress of intermolecular autophosphorylat
AhSYMRK (Unbound, 45 kDa): white and black arrowheads beside the autoradiographs i
concentration on the autophosphorylation potential of native AhSYMRK (WT) and pY670-
log of velocity versus the log of enzyme concentration where the data were produced by
panel).kinase [6] suggesting that charged residues in the hydrophobic
pocket deep within the active site destabilize the catalytic groove.
In addition, phosphorylation on the gatekeeper residue can affect
the hydrophobic connectivity in the catalytic spine of the kinase
to inactivate it [4,6]. A charged residue in the gatekeeper position
could also interfere with the relative orientations of the two lobes
in AhSYMRK by interfering with its hinge-bending motions [30].
Whatever be the underlying mechanism of inactivation, our results
clearly indicate that autophosphorylation on the gatekeeper Tyr
(Y670) inactivates AhSYMRK and suggests an important role of
phosphorylation/dephosphorylation of gatekeeper tyrosine in
determining the catalytic output of AhSYMRK.
3.5. Activation of intramolecular autophosphorylation
in pY670-depleted AhSYMRK
We next attempted to compare the catalytic activity of native
AhSYMRK with its pY670-depleted form (Unbound, Fig. 4A). For
this, we monitored the progress of in vitro autophosphorylation ofEnrichment of pTyr-containing AhSYMRK by sequential immunoprecipitation (IP):
AhSYMRK were subjected to immunoblot analysis using a-pY670 (665–674) (upper
ns ± SEM (n = 3 experiments). (B) Autophosphorylation potential of pY670-enriched
ound and Unbound fractions. (C) Comparison of the catalytic potential of native
and pY670-depleted AhSYMRK (Unbound) were subjected to autophosphorylation
hosphorylation. (C, lower panel) Densitometric analysis where the data are presented
ion of Trx-K625E (53 kDa) by native WT AhSYMRK (45 kDa) and pY670-depleted
ndicate the positions of Trx-K625E and AhSYMRK, respectively. (E) Effect of enzyme
depleted AhSYMRK (Unbound): autoradiograph (left panel) and van’t Hoff plot of the
scintillation counting and are represented as means ± SEM (n = 3 experiments) (right
Fig. 5. Proposed model for gatekeeper phosphorylation mediated inactivation of
AhSYMRK. (A) In a homology model (generated on 2OID_B, Supplemental Fig. S2),
Y670 (red), the invariant glutamate from a-helix C (E641, cyan) and the aspartate
from DFG motif (F742, violet) are in H-bonding distance which is a signature of an
active conformation for several kinases [9]. The corresponding distances between
these residues are also indicated. (B) A simulated phosphate moiety on Y670
appeared to clash with E641 and K625 resulting in probable destabilization of the
A. Paul et al. / FEBS Letters 588 (2014) 2881–2889 2887AhSYMRK and the pY670-depleted fractions where autophosphory-
lation was noted to be signiﬁcantly higher in the pY670-depleted
AhSYMRK fraction (Fig. 4C). By estimating the radioactivity
incorporated in the corresponding bands it was found that there
was 15-fold increase in the autophosphorylation level by the
depletion of pY670-AhSYMRK from the native preparation
(Fig. 4C). The two-fold reduction of the inactive form of the
pY670-containing AhSYMRK in the depleted fraction (Fig. 4A) could
not account for the15-fold increase in autophosphorylation of the
pY670-depleted AhSYMRK fraction (Fig. 4C) and suggested that
pY670 inhibited autophosphorylation activity of the kinase. Or in
other words, phosphorylation on gatekeeper tyrosine appeared to
be autoinhibitory.
Like several other RLKs, AhSYMRK autophosphorylated in both
an intra and intermolecular manner [43–45]. Our next objective
was to understand whether the observed inhibition was targeted
to intra or intermolecular autophosphorylation or both. For that
similar progress curves of the native and the pY670-depleted
AhSYMRK were developed in the presence of the catalytically dead
kinase (Trx-K625E-AhSYMRK). As shown in Fig. 4D, the increased
autophosphorylation on the pY670-depleted AhSYMRK was intra-
molecular as phosphorylation on Trx-K625E-AhSYMRK mutant
remained relatively unaffected by depletion of pY670-containing
AhSYMRK. However, these results did not eliminate the possibility
of hierarchical or processive intermolecular autophosphorylation
events that could only be undertaken by an active kinase [46]. To
clarify this possibility, we analysed autophosphorylation by the
pY670-depleted AhSYMRK fraction over a series of dilutions (up
to 40-fold) (Fig. 4E). van’t Hoff analysis of the data using linear
regression produced a slope of 1.05 with a correlation coefﬁcient
of 0.97 indicating the mechanism of increased self-phosphoryla-
tion of the kinase by pY670 depletion to be intramolecular. Based
on these ﬁndings, we conclude that autophosphorylation on gate-
keeper tyrosine was autoinhibitory towards intramolecular auto-
phosphorylation undertaken by active AhSYMRK. Overall, data in
this section show autophosphorylation on gatekeeper tyrosine to
impede the activity of AhSYMRK.active site.4. Summary
AhSYMRK autophosphorylated on gatekeeper tyrosine though
phosphorylation on this site was not necessary for the kinase activ-
ity [17]. In this report we demonstrate that gatekeeper tyrosine
autophosphorylation (pY670) inactivated AhSYMRK. To demon-
strate how phosphorylation on the gatekeeper Tyr (pY670) might
inﬂuence the architecture of the catalytic groove, we developed a
homology model of AhSYMRK based on IRAK4 (PDB ID: 2OID_B)
(Supplemental Fig. S2). As indicated in Fig. 5A, the conserved Glu
(E641) in a-helix C appeared to be within H-bonding distance with
Y670 as well as with the backbone of a Phe residue (F742) in the
DFG motif of the activation segment. The corresponding residues
in IRAK4 (2OID_B) forms a H-bonding network that is considered
to be a signature of the activated state of both IRAK4 [10,11] and
other RLKs [9]. Insertion of a phosphate group on gatekeeper Tyr
(Y670) in AhSYMRK model indicates a probable steric clash and
charge repulsion with E641 in a-helix C (Fig. 5B) which could disor-
ganise the H-bond network and uncouple the salt-bridge interac-
tion between E641 with K625. This destabilisation of the catalytic
groove is a plausible explanation for the strong reduction of cata-
lytic activity in AhSYMRK phosphorylated in gatekeeper tyrosine.
In addition, depletion of the gatekeeper phosphorylated inactive
form of AhSYMRK activated intramolecular autophosphorylation of
the kinase suggesting gatekeeper tyrosine phosphorylation to have
an autoinhibitory effect on this RLK. This is the ﬁrst report of gate-
keeper phosphorylation mediated inhibition of protein kinases thatadds another evidence in favour of hinge region having an impor-
tant role in autoinhibition of protein kinases. Usually, autoinhibito-
ry domains are localized outside the kinase domain [47,48] but
several evidences indicate the role of hinge regionwithin the kinase
domain to have an autoinhibitory effect on protein kinases. These
evidences include (i) autoinhibitory network of H-bonds at the
hinge region known as a ‘molecular brake’ in RTKs [49], (ii) intra-
molecular autoinhibitory interaction of aC-b4 loop with activation
loop of ErbB2 receptor kinase [50], (iii) autoinhibited conformation
of the GCN2 by an arginine residue mediated rigidiﬁcation of hinge
region [51], (iv) autoinhibition of NEK7 kinase by preventing the
interaction of its gatekeeper leucine with another leucine in the
aC loop [52], (v) a cluster of hydrophobic residues that interact with
the gatekeeper form a novel structural unit that restrain backbone
ﬂexibility at the activation loop through an intramolecular pathway
of connectivity in ERK2 [7]. Therefore it appears that the hinge
region alongwith the gatekeeper serves as a potential mediator of
autoinhibition in protein kinases. Since presence of a gatekeeper
tyrosine residue is a conserved feature in RLKs, it remains to be seen
whether phosphorylation on gatekeeper tyrosine and its autoinhib-
itory effects are of widespread occurrence in RLKs.
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